Nestlé is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years. Under its new Vital Pursuit brand, the global food giant plans to launch 12 products ranging from frozen protein pasta, sandwich melts and pizzas, all of which are made with a higher amount of protein and essential nutrients like iron, vitamin A and potassium.
agonists are a class of Type 2 diabetes drugs that improves blood sugar control but may also lead to weight loss. Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, which is the active ingredient in Eli Lily's Mounjaro and Zepbound, are considered GLP-1 drugs. They have surged in popularity in recent years as people touted the drugs' weight-loss effects.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 usersNestle's Vital Pursuit brand's initial lineup of 12 items will include frozen bowls with whole grains or protein pasta, sandwich melts and pizzas.
Source: CNBC - 🏆 12. / 72 Read more »
Nestle Set to Sell $5 Pizza, Sandwiches for Wegovy, Ozempic UsersNestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as...
Source: Medscape - 🏆 386. / 55 Read more »
Nestlé Launching Frozen Food Brand For Ozempic UsersCailey Gleeson is a reporter who covers breaking news, with a frequent focus on politics, business and legal matters.
Source: Forbes - 🏆 394. / 53 Read more »
Nestle to launch frozen pizzas, other foods targeting users of weight-loss drugsNestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing market of consumers who are using GLP-1 drugs like Ozempic and Wegovy.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.Before insurance, Novo Nordisk charges about $1,000 per month for Ozempic in the United States. In Germany, the company charges $59 a month for the same drug.
Source: CNBC - 🏆 12. / 72 Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyA U.S. Senate committee said on Wednesday it had launched an investigation into the prices of Novo Nordisk's diabetes and weight loss drugs Ozempic and Wegovy in the United States.
Source: Reuters - 🏆 2. / 97 Read more »